| Literature DB >> 35207797 |
Mohamad Mahmoud Al Rahhal1, Yakoub Bazi2, Rami M Jomaa3, Ahmad AlShibli4, Naif Alajlan2, Mohamed Lamine Mekhalfi4, Farid Melgani5.
Abstract
The steady spread of the 2019 Coronavirus disease has brought about human and economic losses, imposing a new lifestyle across the world. On this point, medical imaging tests such as computed tomography (CT) and X-ray have demonstrated a sound screening potential. Deep learning methodologies have evidenced superior image analysis capabilities with respect to prior handcrafted counterparts. In this paper, we propose a novel deep learning framework for Coronavirus detection using CT and X-ray images. In particular, a Vision Transformer architecture is adopted as a backbone in the proposed network, in which a Siamese encoder is utilized. The latter is composed of two branches: one for processing the original image and another for processing an augmented view of the original image. The input images are divided into patches and fed through the encoder. The proposed framework is evaluated on public CT and X-ray datasets. The proposed system confirms its superiority over state-of-the-art methods on CT and X-ray data in terms of accuracy, precision, recall, specificity, and F1 score. Furthermore, the proposed system also exhibits good robustness when a small portion of training data is allocated.Entities:
Keywords: COVID-19; X-ray images; computed tomography; deep learning; vision transformer
Year: 2022 PMID: 35207797 PMCID: PMC8876295 DOI: 10.3390/jpm12020310
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Figure 1The overall structure of the proposed model.
Figure 2Samples of patients from the COVIDx dataset: (a) healthy (normal), (b) pneumonia, and (c) COVID-19.
Numbers of images per class in the COVIDX dataset.
| Normal | Pneumonia | COVID-19 | |
|---|---|---|---|
| Train | 66 | 5438 | 258 |
| Test | 100 | 100 | 100 |
| Total | 8066 | 5538 | 358 |
Figure 3Samples of patients from the CT dataset: (a) non-COVID-19 and (b) COVID-19.
Classification results (expressed as a percent) obtained on the COVIDX dataset.
| Overall | Per Class | |||
|---|---|---|---|---|
| Normal | COVID-19 | Pneumonia | ||
| Accuracy | 94.62 | 96.61 | 90 | 92.42 |
| Precision | 96.77 | 95.21 | 92.84 | 94.17 |
| Recall | 96.77 | 97.61 | 90 | 92.42 |
| Specificity | 99.65 | 93.7 | 99.43 | 96.53 |
| F1 | 96.77 | 95.91 | 90.91 | 93.29 |
Figure 4Confusion matrix for the evaluation on test set of COVIDx dataset, where the labels 0, 1, and 2 represents the normal, COVID-19, and pneumonia classes, respectively.
Figure 5Heat maps of the COVIDx images: (a) COVID-19 and (b) pneumonia.
Classification results (expressed as a percent) obtained on the CT dataset with a split of 60:40.
| Trial 1 | Trial 2 | Trial 3 | Avg ± sd. | |
|---|---|---|---|---|
| Accuracy | 99.09 | 99.19 | 99.59 | 99.29 ± 0.26 |
| Precision | 98.57 | 99.39 | 99.41 | 99.12 ± 0.48 |
| Recall | 99.58 | 98.98 | 99.8 | 99.45 ± 0.42 |
| Specificity | 98.61 | 99.39 | 99.38 | 99.13 ± 0.45 |
| F1 | 99.08 | 99.18 | 99.68 | 99.31 ± 0.32 |
Classification results (expressed as a percent) obtained on the CT dataset with a split of 80:20.
| Trial 1 | Trial 2 | Trial 3 | Avg ± sd. | |
|---|---|---|---|---|
| Accuracy | 99.40 | 98.99 | 98.99 | 99.13 ± 0.23 |
| Precision | 98.77 | 99.60 | 100.00 | 99.46 ± 0.63 |
| Recall | 100.00 | 98.41 | 99.5 | 98.82 ± 1.04 |
| Specificity | 99.82 | 99.59 | 100.00 | 99.47 ± 0.6 |
| F1 | 99.38 | 99.00 | 99.01 | 99.13 ± 0.22 |
Classification results (expressed as a percent) obtained on the CT dataset with a split of 20:80.
| Trial 1 | Trial 2 | Trial 3 | Avg ± sd. | |
|---|---|---|---|---|
| Accuracy | 99.55 | 99.01 | 99.55 | 99.37 ± 0.31 |
| Precision | 99.6 | 98.18 | 99.6 | 99.13 ± 0.82 |
| Recall | 99.5 | 99.79 | 99.5 | 99.6 ± 0.17 |
| Specificity | 99.6 | 98.28 | 99.6 | 99.16 ± 0.76 |
| F1 | 99.55 | 98.98 | 99.55 | 99.36 ± 0.33 |
Figure 6Heat maps of CT images of COVID-19 cases.
Classification results (expressed as a percent) obtained on the CT dataset with a split of 80:20, 60:40, and 20:80.
| Training-to-Testing Ratio (%) | Accuracy | Precision | Recall | F1 | |
|---|---|---|---|---|---|
| Alrahhal et al. [ | 80:20 | 99.24 | 99.16 | 99.25 | 99.21 |
| Soares et al. [ | 97.38 | 99.16 | 95.53 | 97.31 | |
| Silva et al. [ | 98.99 | 99.20 | 98.80 | 98.99 | |
| Proposed | 99.13 | 99.46 | 98.82 | 99.13 | |
| Alrahhal et al. [ | 60:40 | 98.65 | 97.81 | 99.41 | 98.60 |
| Pathak et al. [ | 98.37 | 98.74 | 98.87 | 98.14 | |
| Proposed | 99.29 | 99.12 | 99.45 | 99.31 | |
| Alrahhal et al. [ | 20:80 | 96.16 | 96.90 | 95.41 | 96.15 |
| Proposed | 99.37 | 99.13 | 99.60 | 99.36 |